Toronto, Ontario--(Newsfile Corp. - Le juin 2/June 2022) - The common shares of Origin Therapeutics Holdings Inc. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Origin Therapeutics Holdings is an actively managed investment issuer focused...